Inozume et al. pre-selected CD8+ PD-1+ T cells using the FACS method and immunomagnetic beads, and these cells showed greater tumor reactivity when compared to CD8+ PD-1− or non-selected TILs [50]. The gene discussed is PDCD1; the disease is neoplasm.